 | • レポートコード：MRC2Q12-18901 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ブプロピオンのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ブプロピオンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ブプロピオンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ブプロピオンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのブプロピオンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のブプロピオンの売上および2028年までの予測に焦点を当てています。 ブプロピオンのグローバル主要企業には、GSK、Actavis Laboratories、Anchen Pharmaceuticals、Epic Pharma、Impax Laboratories、InvaGen (a Cipla subsidiary)、Prinston Pharmaceutical、ScieGen Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ブプロピオン市場は、タイプとアプリケーションによって区分されます。世界のブプロピオン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 即時リリース（IR）、持続リリース（SR）、拡張リリース（XR） 【アプリケーション別セグメント】 病院薬局、小売薬局、オンライン薬局 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ブプロピオン製品概要 - タイプ別市場（即時リリース（IR）、持続リリース（SR）、拡張リリース（XR）） - アプリケーション別市場（病院薬局、小売薬局、オンライン薬局） - 調査の目的 ・エグゼクティブサマリー - 世界のブプロピオン販売量予測2017-2028 - 世界のブプロピオン売上予測2017-2028 - ブプロピオンの地域別販売量 - ブプロピオンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ブプロピオン販売量 - 主要メーカー別ブプロピオン売上 - 主要メーカー別ブプロピオン価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（即時リリース（IR）、持続リリース（SR）、拡張リリース（XR）） - ブプロピオンのタイプ別販売量 - ブプロピオンのタイプ別売上 - ブプロピオンのタイプ別価格 ・アプリケーション別市場規模（病院薬局、小売薬局、オンライン薬局） - ブプロピオンのアプリケーション別販売量 - ブプロピオンのアプリケーション別売上 - ブプロピオンのアプリケーション別価格 ・北米市場 - 北米のブプロピオン市場規模（タイプ別、アプリケーション別） - 主要国別のブプロピオン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのブプロピオン市場規模（タイプ別、アプリケーション別） - 主要国別のブプロピオン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のブプロピオン市場規模（タイプ別、アプリケーション別） - 主要国別のブプロピオン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のブプロピオン市場規模（タイプ別、アプリケーション別） - 主要国別のブプロピオン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのブプロピオン市場規模（タイプ別、アプリケーション別） - 主要国別のブプロピオン市場規模（トルコ、サウジアラビア） ・企業情報 GSK、Actavis Laboratories、Anchen Pharmaceuticals、Epic Pharma、Impax Laboratories、InvaGen (a Cipla subsidiary)、Prinston Pharmaceutical、ScieGen Pharmaceuticals ・産業チェーン及び販売チャネル分析 - ブプロピオンの産業チェーン分析 - ブプロピオンの原材料 - ブプロピオンの生産プロセス - ブプロピオンの販売及びマーケティング - ブプロピオンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ブプロピオンの産業動向 - ブプロピオンのマーケットドライバー - ブプロピオンの課題 - ブプロピオンの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Bupropion is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Bupropion is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Bupropion is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Bupropion include GSK, Actavis Laboratories, Anchen Pharmaceuticals, Epic Pharma, Impax Laboratories, InvaGen (a Cipla subsidiary), Prinston Pharmaceutical and ScieGen Pharmaceuticals, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Bupropion manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Bupropion market. Further, it explains the major drivers and regional dynamics of the global Bupropion market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
GSK
Actavis Laboratories
Anchen Pharmaceuticals
Epic Pharma
Impax Laboratories
InvaGen (a Cipla subsidiary)
Prinston Pharmaceutical
ScieGen Pharmaceuticals
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Bupropion Segment by Type
Immediate Release (IR)
Sustained Release (SR)
Extended Release (XR)
Bupropion Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Bupropion market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Bupropion, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Bupropion, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Bupropion, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bupropion sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Bupropion market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Bupropion sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GSK, Actavis Laboratories, Anchen Pharmaceuticals, Epic Pharma, Impax Laboratories, InvaGen (a Cipla subsidiary), Prinston Pharmaceutical and ScieGen Pharmaceuticals, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Bupropion in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Bupropion manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bupropion sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Bupropion Product Introduction
1.2 Market by Type
1.2.1 Global Bupropion Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immediate Release (IR)
1.2.3 Sustained Release (SR)
1.2.4 Extended Release (XR)
1.3 Market by Application
1.3.1 Global Bupropion Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bupropion Sales Estimates and Forecasts 2017-2028
2.2 Global Bupropion Revenue Estimates and Forecasts 2017-2028
2.3 Global Bupropion Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Bupropion Sales by Region
2.4.1 Global Bupropion Sales by Region (2017-2022)
2.4.2 Global Sales Bupropion by Region (2023-2028)
2.5 Global Bupropion Revenue by Region
2.5.1 Global Bupropion Revenue by Region (2017-2022)
2.5.2 Global Bupropion Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Bupropion Sales by Manufacturers
3.1.1 Global Top Bupropion Manufacturers by Sales (2017-2022)
3.1.2 Global Bupropion Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bupropion in 2021
3.2 Global Bupropion Revenue by Manufacturers
3.2.1 Global Bupropion Revenue by Manufacturers (2017-2022)
3.2.2 Global Bupropion Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Bupropion Revenue in 2021
3.3 Global Bupropion Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bupropion Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bupropion Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bupropion Sales by Type
4.1.1 Global Bupropion Historical Sales by Type (2017-2022)
4.1.2 Global Bupropion Forecasted Sales by Type (2023-2028)
4.1.3 Global Bupropion Sales Market Share by Type (2017-2028)
4.2 Global Bupropion Revenue by Type
4.2.1 Global Bupropion Historical Revenue by Type (2017-2022)
4.2.2 Global Bupropion Forecasted Revenue by Type (2023-2028)
4.2.3 Global Bupropion Revenue Market Share by Type (2017-2028)
4.3 Global Bupropion Price by Type
4.3.1 Global Bupropion Price by Type (2017-2022)
4.3.2 Global Bupropion Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Bupropion Sales by Application
5.1.1 Global Bupropion Historical Sales by Application (2017-2022)
5.1.2 Global Bupropion Forecasted Sales by Application (2023-2028)
5.1.3 Global Bupropion Sales Market Share by Application (2017-2028)
5.2 Global Bupropion Revenue by Application
5.2.1 Global Bupropion Historical Revenue by Application (2017-2022)
5.2.2 Global Bupropion Forecasted Revenue by Application (2023-2028)
5.2.3 Global Bupropion Revenue Market Share by Application (2017-2028)
5.3 Global Bupropion Price by Application
5.3.1 Global Bupropion Price by Application (2017-2022)
5.3.2 Global Bupropion Price Forecast by Application (2023-2028)
6 North America
6.1 North America Bupropion Market Size by Type
6.1.1 North America Bupropion Sales by Type (2017-2028)
6.1.2 North America Bupropion Revenue by Type (2017-2028)
6.2 North America Bupropion Market Size by Application
6.2.1 North America Bupropion Sales by Application (2017-2028)
6.2.2 North America Bupropion Revenue by Application (2017-2028)
6.3 North America Bupropion Market Size by Country
6.3.1 North America Bupropion Sales by Country (2017-2028)
6.3.2 North America Bupropion Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Bupropion Market Size by Type
7.1.1 Europe Bupropion Sales by Type (2017-2028)
7.1.2 Europe Bupropion Revenue by Type (2017-2028)
7.2 Europe Bupropion Market Size by Application
7.2.1 Europe Bupropion Sales by Application (2017-2028)
7.2.2 Europe Bupropion Revenue by Application (2017-2028)
7.3 Europe Bupropion Market Size by Country
7.3.1 Europe Bupropion Sales by Country (2017-2028)
7.3.2 Europe Bupropion Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Bupropion Market Size by Type
8.1.1 Asia Pacific Bupropion Sales by Type (2017-2028)
8.1.2 Asia Pacific Bupropion Revenue by Type (2017-2028)
8.2 Asia Pacific Bupropion Market Size by Application
8.2.1 Asia Pacific Bupropion Sales by Application (2017-2028)
8.2.2 Asia Pacific Bupropion Revenue by Application (2017-2028)
8.3 Asia Pacific Bupropion Market Size by Region
8.3.1 Asia Pacific Bupropion Sales by Region (2017-2028)
8.3.2 Asia Pacific Bupropion Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Bupropion Market Size by Type
9.1.1 Latin America Bupropion Sales by Type (2017-2028)
9.1.2 Latin America Bupropion Revenue by Type (2017-2028)
9.2 Latin America Bupropion Market Size by Application
9.2.1 Latin America Bupropion Sales by Application (2017-2028)
9.2.2 Latin America Bupropion Revenue by Application (2017-2028)
9.3 Latin America Bupropion Market Size by Country
9.3.1 Latin America Bupropion Sales by Country (2017-2028)
9.3.2 Latin America Bupropion Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Bupropion Market Size by Type
10.1.1 Middle East and Africa Bupropion Sales by Type (2017-2028)
10.1.2 Middle East and Africa Bupropion Revenue by Type (2017-2028)
10.2 Middle East and Africa Bupropion Market Size by Application
10.2.1 Middle East and Africa Bupropion Sales by Application (2017-2028)
10.2.2 Middle East and Africa Bupropion Revenue by Application (2017-2028)
10.3 Middle East and Africa Bupropion Market Size by Country
10.3.1 Middle East and Africa Bupropion Sales by Country (2017-2028)
10.3.2 Middle East and Africa Bupropion Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Bupropion Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Bupropion Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Actavis Laboratories
11.2.1 Actavis Laboratories Corporation Information
11.2.2 Actavis Laboratories Overview
11.2.3 Actavis Laboratories Bupropion Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Actavis Laboratories Bupropion Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Actavis Laboratories Recent Developments
11.3 Anchen Pharmaceuticals
11.3.1 Anchen Pharmaceuticals Corporation Information
11.3.2 Anchen Pharmaceuticals Overview
11.3.3 Anchen Pharmaceuticals Bupropion Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Anchen Pharmaceuticals Bupropion Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Anchen Pharmaceuticals Recent Developments
11.4 Epic Pharma
11.4.1 Epic Pharma Corporation Information
11.4.2 Epic Pharma Overview
11.4.3 Epic Pharma Bupropion Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Epic Pharma Bupropion Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Epic Pharma Recent Developments
11.5 Impax Laboratories
11.5.1 Impax Laboratories Corporation Information
11.5.2 Impax Laboratories Overview
11.5.3 Impax Laboratories Bupropion Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Impax Laboratories Bupropion Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Impax Laboratories Recent Developments
11.6 InvaGen (a Cipla subsidiary)
11.6.1 InvaGen (a Cipla subsidiary) Corporation Information
11.6.2 InvaGen (a Cipla subsidiary) Overview
11.6.3 InvaGen (a Cipla subsidiary) Bupropion Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 InvaGen (a Cipla subsidiary) Bupropion Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 InvaGen (a Cipla subsidiary) Recent Developments
11.7 Prinston Pharmaceutical
11.7.1 Prinston Pharmaceutical Corporation Information
11.7.2 Prinston Pharmaceutical Overview
11.7.3 Prinston Pharmaceutical Bupropion Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Prinston Pharmaceutical Bupropion Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Prinston Pharmaceutical Recent Developments
11.8 ScieGen Pharmaceuticals
11.8.1 ScieGen Pharmaceuticals Corporation Information
11.8.2 ScieGen Pharmaceuticals Overview
11.8.3 ScieGen Pharmaceuticals Bupropion Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 ScieGen Pharmaceuticals Bupropion Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 ScieGen Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bupropion Industry Chain Analysis
12.2 Bupropion Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bupropion Production Mode & Process
12.4 Bupropion Sales and Marketing
12.4.1 Bupropion Sales Channels
12.4.2 Bupropion Distributors
12.5 Bupropion Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bupropion Industry Trends
13.2 Bupropion Market Drivers
13.3 Bupropion Market Challenges
13.4 Bupropion Market Restraints
14 Key Findings in The Global Bupropion Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer